1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Investigación quirúrgica en urología y trasplante renal

Investigación quirúrgica en urología y trasplante renal

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Mata Alcaraz M, Mínguez Ojeda C, Artiles Medina A, Duque Ruiz G, Hevia Palacios M, Arias Fúnez F, Burgos Revilla FJ.

    Extracorporeal shock wave lithotripsy for lower calyx stones: predicting treatment success.

    Actas Urologicas Espanolas . : .

    [doi:10.1016/j.acuroe.2023.07.004]

  • Schwartzmann I, García Barreras S, D'Anna M, Parejo V, Torneo Ruiz I, Tagalos Muñoz AC, Bravo-Balado A, Diana P, Peri L, Domínguez Esteban M, Fernández Guzmán E.

    Water vapor thermal therapy: Technical variations among spanish hospitals and efficacy at 2-year follow-up.

    Actas Urologicas Espanolas . : .

    [doi:10.1016/j.acuroe.2023.07.001]

  • Guerrero P, Albarrán V, González-Merino C, García de Quevedo C, Sotoca P, Chamorro J, Rosero DI, Barrill A, Alía V, Calvo JC, Moreno J, Pérez de Aguado P, Álvarez-Ballesteros P, San Román M, Serrano JJ, Soria A, Olmedo ME, Saavedra C, Cortés A, Gómez A, Lage Y, Ruiz Á, Ferreiro MR, Longo F, Guerra E, Martínez-Delfrade Í, Garrido P, Gajate P.

    Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients.

    ONCOLOGIST . : .

    [doi:10.1093/oncolo/oyae284]

  • Rivero Belenchón I, Congregado Ruíz CB, Gómez Ciriza G, Gómez Dos Santos V, Burgos Revilla FJ, Medina López RA.

    Reply by Authors.

    The Journal of urology . : .

    [doi:10.1097/JU.0000000000004462]

  • Rivero Belenchón I, Congregado Ruíz CB, Gómez Ciriza G, Gómez Dos Santos V, Burgos Revilla FJ, Medina López RA.

    Reply by Authors.

    The Journal of urology . : .

    [doi:10.1097/JU.0000000000004469]

  • Pérez-Gutiérrez AM, Flórez G, Blanco V, Vázquez FL, Abellí-Deulofeu E, Ortega L, Serrano A, Arias F, Navarrete F, Fonseca F, Estévez V, Gómez Trigo J, Facal F, Arrojo M, Manzanares J, Muga R, Miquel L, Rodríguez de Fonseca F, Torrens M, Rubio G, Costas J.

    Predictive performance for alcohol use disorder of polygenic scores based on the general addiction risk factor and problematic alcohol use.

    DRUG AND ALCOHOL DEPENDENCE . 276: 112877-112877.

    [doi:10.1016/j.drugalcdep.2025.112877]

  • López CL, Sambo M, Orcajo-Rincon L, Durán-Poveda M, García JR, Santos RJ, Muñoz ML, Navarro-González E, Aller J, Pubul V, Guadalix S, Crespo G, González C, Zafón C, Navarro M, Sandi JS, Segura Á, Gajate P, Gómez-Balaguer M, Valdivia J, Reverter JL, Galofré JC, Castelo B, Villanueva MJ, Argüelles I, Casas JAV.

    Clinical and treatment patterns of advanced and radioiodine-refractory differentiated thyroid cancer. ERUDIT study.

    CLINICAL & TRANSLATIONAL ONCOLOGY . : .

    [doi:10.1007/s12094-025-04122-6]

  • Büttner T, Rizzo M, Bernal Vaca L, Molina-Cerrillo J, Alonso-Gordoa T, Juárez A, Buchler T, Seront E, Kucharz J, Gandur Quiroga MN, Bourlon MT, Bögemann M, Kopecky J, Rescigno P, Fiala O, Rodriguez-Vida A, Myint ZW, Ürün Y, Scagliarini S, Poprach A, Matthews D, Li H, Rizzo A, Mosca A, Lenci E, Melichar B, Wenzel M, Mandell P, Massari F, Antonarakis ES, Santoni M.

    Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study.

    PROSTATE CANCER P D . : .

    [doi:10.1038/s41391-025-01067-3]

  • Alonso-Gordoa T, Fernández-Calvo O, García-Carbonero I, Álvarez-Rodríguez S, Sánchez-Escribano R, Anguera G, González-Del-Alba A, Gallardo E, Cacho D, Vidal N, Pinto Á, Perezagua C, Zafra-Poves M, Cassinello J, Rodriguez-Vida A, López-Campos F, Vázquez-Estévez S.

    Patient selection for triplet therapy with darolutamide in metastatic castration-sensitive prostate cancer and patterns of administration: a Spanish multicenter study.

    CLINICAL & TRANSLATIONAL ONCOLOGY . : .

    [doi:10.1007/s12094-025-04174-8]

  • Fernández-Mardomingo Díaz A, Artiles Medina A, López Curtis D, Mínguez Ojeda C, Subiela JD, González Tello F, Sanz Mayayo E, De la Parra Sánchez I, Gómez Dos Santos V, Burgos Revilla FJ.

    Bosniak IIF renal cysts: natural history and the impact of lesion size on progression.

    INTERNATIONAL UROLOGY AND NEPHROLOGY . : .

    [doi:10.1007/s11255-025-04984-3]

  • Gallioli A, Di Bello F, Zattoni F, D'Andrea D, Laukhtina E, Soria F, Afferi L, Del Giudice F, Krajewski W, Marcq G, Lorenzis E, Moschini M, Mari A, Subiela JD, Donnini I, Diéguez L, Izquierdo P, Chung BI, Avesani G, Territo A, Basile G, Palou J, Pradere B, Breda A.

    Risk of Recurrence and Progression After Endoscopic Kidney-sparing Surgery for Upper Tract Urothelial Carcinoma.

    European Urology Oncology . : .

    [doi:10.1016/j.euo.2026.01.002]

  • Klinglmair G, Lutz M, Telia T, van Creij NCH, Wafa H, Tymoszuk P, Heim B, Niedersuess-Beke D, Terbuch A, Subiela JD, Del Giudice F, Mayr R, Luger A, Pichler R.

    Sarcopenia and recurrence risk in high-risk non-muscle-invasive bladder cancer: a nonlinear modeling approach.

    JOURNAL OF NUTRITION HEALTH & AGING . 30(4): 100805-100805.

    [doi:10.1016/j.jnha.2026.100805]

  • Scilipoti P, Zaurito P, Longoni M, Tremolada G, Occhi A, Dutto D, Katzendorn O, Krajewski W, Laukhtina E, Elena JLR, Aranda J, Contieri R, Hurle R, Subiela JD, Lucena PE, Fernández A, Marcq G, Szostek A, Pichler R, Álvarez-Maestro M, Bazán AA, Klatte T, du Biest AM, Ferrando V, Buisan O, López AV, Soria F, Pradere B, D Andrea D, Shariat SF, Colecchia M, Montorsi F, Briganti A, Gontero P, Xylinas E, Moschini M.

    Impact of BCG failure patterns on efficacy of intravesical gemcitabine/docetaxel in high-risk non-muscle-invasive bladder cancer.

    BJU INTERNATIONAL . : .

    [doi:10.1111/bju.70182]

  • Longoni M, Scilipoti P, De Angelis M, Zaurito P, Tremolada G, Santangelo A, Simone G, Mastroianni R, Lonati C, Zamboni S, Suardi N, Marcq G, Szostek A, Velasco JC, Lafuente Puentedura A, Subiela JD, Del Olmo Durán P, Slusarczyk A, Karakiewicz PI, Pradere B, Soria F, Gontero P, Rouprêt M, Montorsi F, Salonia A, Briganti A, Moschini M.

    Real-world Adherence to European Association of Urology-recommended Non-muscle-invasive Bladder Cancer Management: From Evidence-based Practice to Oncological Outcomes.

    European Urology Oncology . : .

    [doi:10.1016/j.euo.2026.02.005]

  • Calabrò C, Ciccimarra F, Rizzo A, Cazzato G, Della Mura M, Taha T, Bourlon MT, Melichar B, Studentova H, Schieber TJ, Nardulli P, Molina-Cerrillo J, Monteiro FSM, Soares A, Massafra R, Mollica V, Massari F, Kucharz J, Santoni M.

    Belzutifan monotherapy and combination therapies in renal cell carcinoma: a clinical trial perspective from the ARON working group.

    EXPERT OPINION ON PHARMACOTHERAPY . : 1-11.

    [doi:10.1080/14656566.2026.2627934]

  • Ortega Polledo LE, Sánchez Pellejero A, Bianchini Hernández GFJ, García Rico E, Redondo González E, Subiela Henríquez JD, Mata Deniz P, Marugán Álvarez MJ, Gómez Rivas J, Galante Romo I, Moreno Sierra J, Ahyai S, Miñana B, Alonso Y Gregorio S.

    Prospective analysis of urinary continence and urethral stricture after Holmium laser enucleation of the prostate (HoLEP): A consecutive 254-case series.

    Actas Urologicas Espanolas . : 501912-501912.

    [doi:10.1016/j.acuroe.2026.501912]

  • Fernández-Mardomingo A, Subiela JD, Artiles Medina A, Krajewski W, Pichler R, van Creij NCH, de la Estella Lucena MP, de la Parra I, Mínguez Ojeda C, Coloma A, Crespo Martínez L, Del Olmo Durán P, González-Padilla DA, Villacampa F, Aumatell J, Scilipoti P, Longoni M, Moschini M, de Angelis M, Caño-Velasco J, Contieri R, Gallioli A, D'Andrea D, Acosta EA, Ajami T, Grobet-Jeandin E, Del Giudice F, Santarelli V, Slusarczyk A, Albisinni S, Soria F, Mertens LS, Tully K, Mari A, Guerrero-Ramos F, Alvarez-Maestro M, Anagua Melendres F, Buisan O, Afferi L, Gajate P, Guerrero P, Saiz A, Pradere B, Burgos Revilla FJ.

    Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups.

    BJU INTERNATIONAL . : .

    [doi:10.1111/bju.70207]